Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455065 | SCV000538732 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Labcorp Genetics |
RCV001521613 | SCV001730983 | benign | Immunodeficiency, common variable, 7 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001653784 | SCV001864287 | benign | not provided | 2018-11-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001521613 | SCV001876303 | benign | Immunodeficiency, common variable, 7 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000455065 | SCV004233594 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 34% of patients studied by a panel of primary immunodeficiencies. Number of patients: 32. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001653784 | SCV005284826 | benign | not provided | criteria provided, single submitter | not provided |